Insider trades
David Malcom Rodman, Chief Officer of Mineralys Therapeutics MLYS, has filed 0 purchases and 52 sales on the open market. Over the past 12 months that comes to a net sale of $13.7M. The latest trade was on 06/17.
David Malcom Rodman
Chief Medical Officer
- Company
- Mineralys Therapeutics MLYS
- First filing
- 23/02/13
- Trades
- 222 trades
- Buys / sales
- 0 / 52
- 12-month net buying
- −$13.7M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MLYS | Open-market sale10b5-1 plan | 06/15–06/17 | 06/17 | 14,474 sh2 trades | $24.19avg. | $350,080.9 | −20.2% |
MLYS | Open-market sale10b5-1 plan | 06/10–06/12 | 06/12 | 8,519 sh2 trades | $24.20avg. | $206,181.57 | −11.8% |
| Open-market sale10b5-1 plan | 05/18 | 05/19 | 417 sh | $27.55 | $11,488.35 | −0.7% | |
MLYS | Open-market sale10b5-1 plan | 05/11–05/13 | 05/13 | 22,575 sh3 trades | $28.91avg. | $652,598.17 | −26.2% |
| Open-market sale10b5-1 plan | 04/17 | 04/21 | 416 sh | $31.33 | $13,033.28 | −0.6% | |
MLYS | Open-market sale10b5-1 plan | 04/13–04/15 | 04/15 | 20,406 sh2 trades | $26.89avg. | $548,685 | −22.6% |
| Open-market sale10b5-1 plan | 04/09 | 04/13 | 2,170 sh | $27.38 | $59,414.6 | −2.8% | |
| Open-market sale10b5-1 plan | 03/17 | 03/17 | 417 sh | $25.65 | $10,696.05 | −0.5% | |
MLYS | Open-market sale10b5-1 plan | 03/12–03/13 | 03/16 | 20,406 sh4 trades | $26.61avg. | $542,966.11 | −21.1% |
| Open-market sale10b5-1 plan | 03/09 | 03/10 | 2,171 sh | $26.84 | $58,269.64 | −2.6% | |
| Open-market sale10b5-1 plan | 02/17 | 02/17 | 417 sh | $27.59 | $11,505.03 | −0.9% | |
MLYS | Open-market sale10b5-1 plan | 02/12–02/13 | 02/13 | 20,404 sh5 trades | $27.93avg. | $569,814.91 | −31.6% |
| Open-market sale10b5-1 plan | 02/09 | 02/11 | 2,171 sh | $30.21 | $65,585.91 | −4.1% | |
| Open-market sale10b5-1 plan | 01/20 | 01/20 | 416 sh | $32.10 | $13,353.6 | −0.8% | |
MLYS | Open-market sale10b5-1 plan | 01/13–01/14 | 01/15 | 19,076 sh2 trades | $32.67avg. | $623,147.62 | −27.4% |
MLYS | Open-market sale10b5-1 plan | 01/09–01/12 | 01/13 | 8,518 sh2 trades | $32.56avg. | $277,363.26 | −12.1% |
MLYS | Open-market sale10b5-1 plan | 01/02–01/05 | 01/06 | 262,752 sh3 trades | $35.25avg. | $9,261,919.64 | −81.0% |
| Open-market sale10b5-1 plan | 25/10/15 | 25/10/15 | 10,369 sh | $43.01 | $445,970.69 | −12.7% | |
MLYS | Open-market sale10b5-1 plan | 25/09/15 | 25/09/16 | 11,367 sh2 trades | $36.00avg. | $409,252.35 | −12.2% |
| Open-market sale10b5-1 plan | 25/08/13 | 25/08/14 | 11,365 sh | $12.93 | $146,949.45 | −10.9% |